What are the management options for a patient with a history of Selective Serotonin Reuptake Inhibitor (SSRI) use, who discontinued 3 months ago and is now experiencing potential Post-Acute Withdrawal Syndrome (PAWS) symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Post-Acute Withdrawal Syndrome (PAWS) After SSRI Discontinuation

For a patient experiencing potential PAWS symptoms 3 months after SSRI discontinuation, the primary approach is supportive care with patient education, environmental safety measures if parasomnias are present, and careful evaluation to distinguish withdrawal from relapse—avoiding reintroduction of the SSRI unless symptoms represent true psychiatric relapse rather than protracted withdrawal. 1, 2

Understanding the Clinical Picture

PAWS represents protracted withdrawal symptoms that can persist for weeks to months after SSRI cessation, contrary to the common misconception that all withdrawal symptoms resolve within 2-4 weeks. 3, 4, 2

Key characteristics of SSRI withdrawal syndrome include:

  • Somatic symptoms: dizziness, fatigue, lethargy, myalgias, chills, headaches, nausea, vomiting, diarrhea, insomnia, imbalance, vertigo, sensory disturbances, and paresthesias 1, 5
  • Psychological symptoms: anxiety, irritability, agitation, and crying spells 5, 4
  • Parasomnia manifestations: sleepwalking or REM behavior disorder can occur during withdrawal states, similar to alcohol and barbiturate withdrawal 1

Critical Differential Diagnosis

The most important clinical distinction is between protracted withdrawal and psychiatric relapse, as misidentification leads to unnecessary long-term medication reinstitution. 4, 2

Symptoms favoring withdrawal over relapse include:

  • Prominent sensory disturbances (paresthesias, "brain zaps") 1, 5
  • Temporal relationship to discontinuation (even if delayed) 4
  • Somatic predominance over pure mood symptoms 5

Evaluate for serotonin syndrome features (hyperreflexia, clonus, muscle rigidity, tremor) if the patient had recent exposure to other serotonergic agents, as these can be misidentified as withdrawal or relapse. 1

Management Algorithm

First-Line Supportive Care

Implement patient education as the cornerstone of management, explaining that sensory disturbances and other withdrawal phenomena are recognized medication effects that typically resolve, even when taking longer than expected. 1, 6

For parasomnias (if present):

  • Remove dangerous objects from the bedroom 1
  • Pad surfaces around the bed 1
  • Use heavy window coverings 1
  • Consider placing the mattress on the floor 1
  • Evaluate for underlying sleep disorders (sleep apnea) that can trigger parasomnias 1

For severe anxiety or agitation:

  • Consider short-term benzodiazepines cautiously, recognizing the risk of creating another withdrawal syndrome 1
  • Implement non-pharmacological interventions including cognitive-behavioral therapy, problem-solving therapy, interpersonal therapy, and integrative strategies (massage, aromatherapy, music therapy) 7

When to Consider Polysomnography

Order polysomnography if parasomnia episodes are recurrent or severe to evaluate for REM behavior disorder or other primary sleep disorders. 1

What NOT to Do

Avoid reintroducing the original SSRI or switching to another antidepressant solely to suppress withdrawal symptoms, as current guidelines suggesting this approach may actually aggravate behavioral toxicity and prove detrimental long-term. 2

The oppositional model of tolerance suggests that reintroducing antidepressants to manage withdrawal can perpetuate the problem rather than resolve it. 2

Special Considerations Based on Original SSRI

The specific SSRI discontinued influences withdrawal risk:

  • Paroxetine: highest risk of severe and prolonged withdrawal symptoms 1, 3, 5
  • Fluvoxamine and sertraline: higher withdrawal rates due to shorter half-lives 1, 5
  • Citalopram: relatively lower risk compared to paroxetine, fluvoxamine, and sertraline 1
  • Fluoxetine: lowest risk due to extended half-life 5

Timeline Expectations

Withdrawal symptoms typically occur within days of discontinuation and last a few weeks with gradual tapering, but many variations exist including late onset and longer persistence of disturbances extending to months. 4, 2

At 3 months post-discontinuation, protracted symptoms are possible but less common, making careful evaluation for other causes (including psychiatric relapse) essential. 4

Common Pitfalls to Avoid

Do not mistake withdrawal symptoms for physical illness, which leads to unnecessary costly tests and treatments. 5

Do not automatically assume symptoms represent psychiatric relapse requiring medication reinstitution, as this can lead to long-term unnecessary medication use. 3, 2

Recognize that personal or family history of parasomnias increases susceptibility to sleep disturbances during withdrawal. 1

References

Guideline

Citalopram Discontinuation and Sleepwalking

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.